1. Temozolomide with or without Radiotherapy in Patients with Newly Diagnosed Glioblastoma Multiforme: A Meta-Analysis
   Enshan Feng et al, 2017, Eur Neurol CrossRef
2. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis
   Yanan Li et al, 2016 CrossRef
3. Evaluation on the diagnostic and prognostic values of long non-coding RNA BLACAT1 in common types of human cancer
   Xiaoli Chen et al, 2017, Mol Cancer CrossRef
4. Peritumoral edema on magnetic resonance imaging predicts a poor clinical outcome in malignant glioma
   CHEN-XING WU et al, 2015 CrossRef
5. Alkaloids of fascaplysin are effective conventional chemotherapeutic drugs, inhibiting the proliferation of C6 glioma cells and causing their death in vitro
   Igor Bryukhovetskiy et al, 2017 CrossRef
6. Downregulation of Pygopus 2 inhibits vascular mimicry in glioma U251 cells by suppressing the canonical Wnt signaling pathway
   HAIDONG WANG et al, 2016 CrossRef
7. Convection-enhanced delivery of cetuximab conjugated iron-oxide nanoparticles for treatment of spontaneous canine intracranial gliomas
   A. Courtenay Freeman et al, 2018, J Neurooncol CrossRef
8. Application of an assay Cascade methodology for a deep preclinical characterization of polymeric nanoparticles as a treatment for gliomas
   Cristina Fornaguera et al, 2018, Drug Delivery CrossRef
9. Down regulation of human telomerase reverse transcriptase (hTERT) expression by BIBR1532 in human glioblastoma LN18 cells
   C. Lavanya et al, 2018, Cytotechnology CrossRef
10. Longevity-Related Gene Transcriptomic Signature in Glioblastoma Multiforme
    Manal S. Fawzy et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
11. A Repurposed Drug for Brain Cancer: Enhanced Atovaquone Amorphous Solid Dispersion by Combining a Spontaneously Emulsifying Component with a Polymer Carrier
    Hiroyuki Takabe et al, 2018, Pharmaceutics CrossRef
12. Early Differentiating Mouse Astroglial Progenitors Share Common Protein Signatures with GL261 Glioma Cells
    Dora Brites, 2016, JSRB CrossRef
13. FoxG1 facilitates proliferation and inhibits differentiation by downregulating FoxO/Smad signaling in glioblastoma
    Lei Wang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
14. Leptomeningeal and intramedullary metastases of glioblastoma multiforme in a patient reoperated during adjuvant radiochemotherapy
    Josip Joachim Grah et al, 2013, World J Surg Onc CrossRef
15. Degradation of Mitochondria and Oxidative Stress as the Main Mechanism of Toxicity of Pristine Graphene on U87 Glioblastoma Cells and Tumors and HS-5 Cells
    Sławomir Jaworski et al, 2019, IJMS CrossRef
16. Integrin α10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival
    Matilda Munksgaard Thorén et al, 2019, Cancers CrossRef
17. Polymeric and Lipid-based Drug Delivery Systems for Treatment of Glioblastoma Multiforme
    Ramesh Duwa et al, 2019, Journal of Industrial and Engineering Chemistry CrossRef
18. The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme
    O. F. Olmez et al, 2014, Clin Transl Oncol CrossRef
19. null
    Ismail M. Meraz et al, 2013 CrossRef
20. SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways
    Yanfang Yang et al, 2019, Cell Commun Signal CrossRef
21. Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme: A Systematic Review
    Li-Juan Yang et al, 2014, Cancer Investigation CrossRef
22. Investigating the use of Raman and immersion Raman spectroscopy for spectral histopathology of metastatic brain cancer and primary sites of origin
    Leanne M. Fullwood et al, 2014, Anal. Methods CrossRef
23. The PHLDB1 rs498872 (11q23.3) polymorphism and glioma risk: A meta-analysis
    Xingchun Gao et al, 2015, Asia-Pac J Clin Oncol CrossRef
24. A Ploidy Increase Promotes Sensitivity of Glioma Stem Cells to Aurora Kinases Inhibition
    Chiara Cilibrasi et al, 2019, Journal of Oncology CrossRef
25. An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk
    Qiang Wu et al, 2016, Mol Neurobiol CrossRef
26. Esculin and its oligomer fractions inhibit adhesion and migration of U87 glioblastoma cells and in vitro angiogenesis
    Imen Mokdad-Bzeouich et al, 2016, Tumor Biol. CrossRef
27. A novel amplification-based approach to enable gene expression profiling from small clinical tumor specimens
    Haya Sarras et al, 2016, J Neurooncol CrossRef
28. In vitroantitumor activities of the lichen compounds olivetoric, physodic and psoromic acid in rat neuron and glioblastoma cells
    Bugrahan Emsen et al, 2016, Pharmaceutical Biology CrossRef
29. AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models
    Edwin Chang et al, 2016, J Neurooncol CrossRef
30. Long Noncoding RNA miR210HG as a Potential Biomarker for the Diagnosis of Glioma
    Weijie Min et al, 2016, PLoS ONE CrossRef
31. Unilateral malignant optic glioma following glioblastoma multiforme in the young: a case report and literature review
    Chia-Ying Lin et al, 2017, BMC Ophthalmol CrossRef
32. Assessment of the proliferation status of glioblastoma cell and tumour tissue after nanoplatinum treatment
    Marta Kutwin et al, 2017, PLoS ONE CrossRef
33. Inhibition of growth of U87MG human glioblastoma cells by Usnea longissima Ach.
    BUGRAHAN EMSEN et al, 2019, An. Acad. Bras. Ciênc. CrossRef
34. Transcriptional modulation of calcium‐permeable AMPA receptor subunits in glioblastoma by MEK–ERK1/2 inhibitors and their role in invasion
    Palaniswamy Ramaswamy et al, 2019, Cell Biol Int CrossRef
35. null
    MELVIN F. LORENZO et al, 2017 CrossRef
36. The CXCL12/CXCR4 axis confers temozolomide resistance to human glioblastoma cells via up-regulation of FOXM1
    Shengwen Wang et al, 2020, Journal of the Neurological Sciences CrossRef
37. PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study
    Ilaria Arduino et al, 2020, International Journal of Pharmaceutics CrossRef
38. Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells
    Jacinth Rajendra et al, 2018, Oncotarget CrossRef
39. Tumour-specific triple-regulated oncolytic herpes virus to target glioma
    Zahid M. Delwar et al, 2016, Oncotarget CrossRef
40. Knockdown of Tousled‑like kinase 1 inhibits survival of glioblastoma multiforme cells
    Kamariah Ibrahim et al, 2020, Int J Mol Med CrossRef
41. Therapeutics and Research Related to Glioblastoma: Advancements and Future Targets
    Vishal Chavda et al, 2020, CDM CrossRef
42. ERBB signaling in CTCs of ovarian cancer and glioblastoma
    Anjali Geethadevi et al, 2017, Genes Cancer CrossRef
43. Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update
    Jen-Fu Hsu et al, 2021, Cancers CrossRef
44. Multivariate signaling regulation by SHP2 differentially controls proliferation and therapeutic response in glioma cells
    Christopher M. Furcht et al, 2014 CrossRef
45. IGFBP2 Is a Potential Master Regulator Driving the Dysregulated Gene Network Responsible for Short Survival in Glioblastoma Multiforme
    Manasa Kalya et al, 2021, Front. Genet. CrossRef
46. The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review
    Elmira Mohtashami et al, 2020, CDM CrossRef
47. Combined inhibition of STAT and Notch signalling effectively suppresses tumourigenesis by inducing apoptosis and inhibiting proliferation, migration and invasion in glioblastoma cells
    Israt Jahan Tulip et al, 2021, Animal Cells and Systems CrossRef
48. null
    Uday Kumar Sukumar et al, 2021 CrossRef
49. PPFIBP1 induces glioma cell migration and invasion through FAK/Src/JNK signaling pathway
    Caihua Dong et al, 2021, Cell Death Dis CrossRef
50. Pretreatment neutrophil-to-lymphocyte/monocyte-to-lymphocyte ratio as prognostic biomarkers in glioma patients
    Chim Sher Ting et al, 2021, Journal of Neuroimmunology CrossRef
51. The Effect of Normoxic and Hypoxic U-87 Glioblastoma Paracrine Secretion on the Modulation of Brain Endothelial Cells
    Mariam Rado et al, 2022, Cells CrossRef
52. The Paracrine Effect of Hypoxic and Normoxic Cancer Secretion on the Proliferation of Brain Endothelial Cells (bEnd.3)
    Mariam Rado et al, 2022, Cells CrossRef
53. Empirical Studies on Effect of Low-Level Laser Treatment on Glioblastoma Multiforme in Combination with Ag-PMMA-PAA Nanoparticles: Paired Red Region Optical-Property Treatment Platform
    Rohini Atluri et al, 2022, Applied Nano CrossRef
54. Pre-Operative Peritumoral Edema and Survival Rate in Glioblastoma Multiforme
    Shui-Yuan Liu et al, 2013, Oncol Res Treat CrossRef
55. Alpha2beta1 Integrin Polymorphism in Diffuse Astrocytoma Patients
    Silvia A. Teixeira et al, 2022, Front. Oncol. CrossRef
56. A Promising Way to Overcome Temozolomide Resistance through Inhibition of Protein Neddylation in Glioblastoma Cell Lines
    Barbara Brandt et al, 2023, IJMS CrossRef
57. Symptom management in adult brain tumours: A literature review
    Rong Zhang et al, 2023, Nursing Open CrossRef
58. Study of Gene Expression in Glioblastoma Hypoxic Model
    Deeksha Sharma et al, 2023, RJPT CrossRef
59. Гліобластома: огляд літератури
    Dipak Chaulagain et al, 2023, INJ CrossRef
60. Investigating the impact of headaches on the quality of life of patients with glioblastoma multiforme: a qualitative study.
    Samuel Robert Bennett et al, 2016, BMJ Open CrossRef
61. Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with ^99mTc and ¹⁷⁷Lu as Potential Receptor Radiopharmaceuticals.
    Agnieszka Majkowska-Pilip et al, 2018, Molecules CrossRef